{"corpus_id":72940547,"paper_sha":"241ed9a9179cce9002cff0dcd8a36e3535a3acd9","doi":"10.1016/S0140-6736(18)32213-X","arxiv_id":null,"pmid":30862377,"pmcid":"6495367","mag_id":2921734131,"dblp_id":null,"acl_id":null,"title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","year":2019,"publication_date":"2019-04-01","venue":"The Lancet","journal":{"name":"Lancet (London, England)","pages":"1505 - 1516","volume":"393"},"journal_issn":null,"journal_title":null,"publication_types":["Study","JournalArticle"],"pubmed_pub_types":["Journal Article","Multicenter Study","Randomized Controlled Trial"],"s2_fields_of_study":["Medicine"],"reference_count":50,"citation_count":417,"influential_citation_count":28,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Antihypertensive Agents","mj":false,"qs":[{"q":"administration & dosage","mj":true,"ui":"Q000008"}],"ui":"D000959"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Glaucoma, Open-Angle","mj":false,"qs":[{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D005902"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Laser Therapy","mj":true,"ui":"D053685"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Ocular Hypertension","mj":false,"qs":[{"q":"therapy","mj":true,"ui":"Q000628"}],"ui":"D009798"},{"d":"Ophthalmic Solutions","mj":true,"ui":"D009883"},{"d":"Quality of Life","mj":false,"ui":"D011788"},{"d":"Trabeculectomy","mj":false,"qs":[{"q":"methods","mj":true,"ui":"Q000379"}],"ui":"D014130"},{"d":"Treatment Outcome","mj":false,"ui":"D016896"}],"chemicals":[{"n":"Antihypertensive Agents","ui":"D000959","reg":"0"},{"n":"Ophthalmic Solutions","ui":"D009883","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"http://www.thelancet.com/article/S014067361832213X/pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/241ed9a9179cce9002cff0dcd8a36e3535a3acd9","s2_open_access_license":"CCBY","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Summary Background Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as first-line treatment. We compared the two. Methods In this observer-masked, randomised controlled trial treatment-naive patients with open angle glaucoma or ocular hypertension and no ocular comorbidities were recruited between 2012 and 2014 at six UK hospitals. They were randomly allocated (web-based randomisation) to initial selective laser trabeculoplasty or to eye drops. An objective target intraocular pressure was set according to glaucoma severity. The primary outcome was health-related quality of life (HRQoL) at 3 years (assessed by EQ-5D). Secondary outcomes were cost and cost-effectiveness, disease-specific HRQoL, clinical effectiveness, and safety. Analysis was by intention to treat. This study is registered at controlled-trials.com (ISRCTN32038223). Findings Of 718 patients enrolled, 356 were randomised to the selective laser trabeculoplasty and 362 to the eye drops group. 652 (91%) returned the primary outcome questionnaire at 36 months. Average EQ-5D score was 0·89 (SD 0·18) in the selective laser trabeculoplasty group versus 0·90 (SD 0·16) in the eye drops group, with no significant difference (difference 0·01, 95% CI −0·01 to 0·03; p=0·23). At 36 months, 74·2% (95% CI 69·3–78·6) of patients in the selective laser trabeculoplasty group required no drops to maintain intraocular pressure at target. Eyes of patients in the selective laser trabeculoplasty group were within target intracoluar pressure at more visits (93·0%) than in the eye drops group (91·3%), with glaucoma surgery to lower intraocular pressure required in none versus 11 patients. Over 36 months, from an ophthalmology cost perspective, there was a 97% probability of selective laser trabeculoplasty as first treatment being more cost-effective than eye drops first at a willingness to pay of £20 000 per quality-adjusted life-year gained. Interpretation Selective laser trabeculoplasty should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice. Funding National Institute for Health Research, Health and Technology Assessment Programme.","claims":[{"public_id":"cl_bbc83ded3fae27925c62c35fed3cd4f2","status":"active","text":"From an ophthalmology cost perspective, selective laser trabeculoplasty first had a 97% probability of being more cost-effective than eye drops first at a willingness to pay of £20,000 per quality-adjusted life-year gained.","confidence":0.99,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bbc83ded3fae27925c62c35fed3cd4f2"},{"public_id":"cl_ab4034422072ad9bde99342119572e22","status":"active","text":"Health-related quality of life at 3 years did not differ significantly between initial selective laser trabeculoplasty and initial eye drops.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_ab4034422072ad9bde99342119572e22"},{"public_id":"cl_eac13f5e6e053fb17146337a49763138","status":"active","text":"Initial selective laser trabeculoplasty should be offered as first-line treatment for open angle glaucoma and ocular hypertension.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_eac13f5e6e053fb17146337a49763138"},{"public_id":"cl_21d8b6234c9191ad539520e32c9db0f7","status":"active","text":"Selective laser trabeculoplasty achieved target intraocular pressure at more visits and avoided glaucoma surgery compared with eye drops.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_21d8b6234c9191ad539520e32c9db0f7"},{"public_id":"cl_c8601e8c83291337b0cab21e35910499","status":"active","text":"Selective laser trabeculoplasty as first treatment left 74.2% of patients requiring no drops at 36 months to keep intraocular pressure at target.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c8601e8c83291337b0cab21e35910499"}],"concepts":[{"public_id":"co_04ccaeaf0662c93724a85bd281efeb3c","status":"active","name":"quality-adjusted life-year","description":"A summary measure combining survival and quality of life used in cost-effectiveness analysis.","types":["economic measure"],"aliases":["QALY"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_04ccaeaf0662c93724a85bd281efeb3c"},{"public_id":"co_2b16323b15e326e39530727a28a45eaf","status":"active","name":"target intraocular pressure","description":"The prespecified intraocular pressure threshold set according to glaucoma severity.","types":["clinical target"],"aliases":["target pressure"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2b16323b15e326e39530727a28a45eaf"},{"public_id":"co_3eeae7cc96e24ecd4f3891af52ab6c91","status":"active","name":"ocular hypertension","description":"Elevated intraocular pressure without established glaucomatous damage.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3eeae7cc96e24ecd4f3891af52ab6c91"},{"public_id":"co_52361188596892907eafb4ba180322d5","status":"active","name":"intraocular pressure","description":"The fluid pressure inside the eye that is monitored and lowered in glaucoma care.","types":["measurement"],"aliases":["IOP"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_52361188596892907eafb4ba180322d5"},{"public_id":"co_8026ccb9d85c83c5d7a143fb9b1839ea","status":"active","name":"glaucoma surgery","description":"Surgical intervention performed to lower intraocular pressure in glaucoma.","types":["treatment"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8026ccb9d85c83c5d7a143fb9b1839ea"},{"public_id":"co_954a16ed922d08a0d0abe9498fe4b4c7","status":"active","name":"health-related quality of life","description":"Patient-reported quality of life related to health status, measured here with EQ-5D.","types":["outcome"],"aliases":["HRQoL"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_954a16ed922d08a0d0abe9498fe4b4c7"},{"public_id":"co_a8c86810d3bd754c6a7c64f3b427fcf5","status":"active","name":"open angle glaucoma","description":"A form of glaucoma characterized by open anterior chamber angles and progressive optic nerve damage.","types":["condition"],"aliases":["primary open angle glaucoma"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a8c86810d3bd754c6a7c64f3b427fcf5"},{"public_id":"co_b681df956fe9aab9627ca3387def35e4","status":"active","name":"cost-effectiveness","description":"An economic evaluation of outcomes relative to costs.","types":["economic outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b681df956fe9aab9627ca3387def35e4"},{"public_id":"co_c8d35a46a8e2c6812b447928ca5625a4","status":"active","name":"eye drops","description":"Topical ocular medications used to lower intraocular pressure.","types":["treatment"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c8d35a46a8e2c6812b447928ca5625a4"},{"public_id":"co_e46975856392eeac1f0ba0b7496dbce3","status":"active","name":"selective laser trabeculoplasty","description":"A laser procedure used to lower intraocular pressure in open-angle eye disease.","types":["treatment"],"aliases":["SLT"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e46975856392eeac1f0ba0b7496dbce3"}],"external_ids":{"DOI":"10.1016/S0140-6736(18)32213-X","ArXiv":null,"PubMed":30862377,"PubMedCentral":"6495367","MAG":2921734131,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"http://www.thelancet.com/article/S014067361832213X/pdf","landing_url":"https://www.semanticscholar.org/paper/241ed9a9179cce9002cff0dcd8a36e3535a3acd9","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631319,"paper_uid":"b867a374-a394-4fde-b202-e1c562dc357b","canonical_identity":{"paper_id":631319,"paper_uid":"b867a374-a394-4fde-b202-e1c562dc357b","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/72940547"}